Literature DB >> 32035893

Hemodynamic Response to Exercise in Patients Supported by Continuous Flow Left Ventricular Assist Devices.

Noah Moss1, Val Rakita1, Anuradha Lala2, Aditya Parikh1, Julie Roldan1, Sumeet S Mitter1, Anelechi Anyanwu3, Michelle Campoli1, Dan Burkhoff4, Donna M Mancini5.   

Abstract

OBJECTIVES: This study sought to characterize the hemodynamic response to exercise in LVAD-supported patients and identify parameters most strongly associated with peak oxygen consumption (VO2).
BACKGROUND: Despite improved survival for heart failure patients afforded by continuous flow left ventricular assist devices (LVADs), peak exercise capacity remains impaired. Mechanisms underlying this reduced functional capacity remain poorly understood.
METHODS: Patients referred for post-VAD hemodynamic optimization from December 2017 through June 2019 were enrolled. Swan Ganz catheters were inserted and upright incremental bicycle ergometry with respiratory gas analysis was performed. Hemodynamic measurements, mixed venous saturation, and arterial blood pressure were recorded every 3 min during exercise. Linear correlations were performed between peak VO2 (ml/min) and peak Fick cardiac output (CO), peak device flow, the assumed intrinsic CO derived as Fick CO-device flow, peak pressure differential across the LVAD (mean arterial pressure-pulmonary capillary wedge pressure), peak pressure differential across right ventricle (mean pulmonary artery pressure - right atrial pressure) and systemic vascular resistance.
RESULTS: Forty-five patients supported by axial flow pumps (n = 12) and centrifugal flow pumps (n = 33) were studied. There were 34 men and 11 women. Age averaged 60 ± 10 years. Peak VO2 averaged 10.6 ± 3.1 ml/kg/min. Fick CO had the greatest correlation with peak VO2 with r = 0.73 (p < 0.0001) followed by intrinsic CO (r = 0.67; p < 0.0001). Multivariate model that best predicted peak VO2 included Fick CO and peak arterial venous oxygen (AVO2) difference.
CONCLUSIONS: LVAD supported patients have severely impaired peak exercise capacity. The peak Fick cardiac output was the best correlate of peak exercise performance.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CPET; exercise; heart failure; left ventricular assist device

Mesh:

Year:  2020        PMID: 32035893     DOI: 10.1016/j.jchf.2019.10.013

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  11 in total

1.  Impact of Mechanical Circulatory Support on Exercise Capacity in Patients With Advanced Heart Failure.

Authors:  Janice Huang; Barry J McDonnell; Justin S Lawley; Jessica Byrd; Eric J Stöhr; William K Cornwell
Journal:  Exerc Sport Sci Rev       Date:  2022-10-01       Impact factor: 6.642

Review 2.  Exercise physiology in left ventricular assist device patients: insights from hemodynamic simulations.

Authors:  Libera Fresiello; Christoph Gross; Steven Jacobs
Journal:  Ann Cardiothorac Surg       Date:  2021-05

3.  Impairments in Blood Pressure Regulation and Cardiac Baroreceptor Sensitivity Among Patients With Heart Failure Supported With Continuous-Flow Left Ventricular Assist Devices.

Authors:  Christine Sailer; Hannah Edelmann; Cullen Buchanan; Pedro Giro; Matthew Babcock; Christine Swanson; Melanie Spotts; Margaret Schulte; Ashley Pratt-Cordova; Greg Coe; Mark Beindorff; Robert L Page; Amrut V Ambardekar; Jay D Pal; Wendy Kohrt; Eugene Wolfel; Justin S Lawley; Takashi Tarumi; William K Cornwell
Journal:  Circ Heart Fail       Date:  2021-01-19       Impact factor: 8.790

Review 4.  Reverse Remodeling With Left Ventricular Assist Devices.

Authors:  Daniel Burkhoff; Veli K Topkara; Gabriel Sayer; Nir Uriel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 23.213

5.  Echo-guided left ventricular assist device speed optimisation for exercise maximisation.

Authors:  Maciej Stapor; Adam Pilat; Andrzej Gackowski; Agnieszka Misiuda; Izabela Gorkiewicz-Kot; Michal Kaleta; Pawel Kleczynski; Krzysztof Zmudka; Jacek Legutko; Boguslaw Kapelak; Karol Wierzbicki
Journal:  Heart       Date:  2022-06-10       Impact factor: 7.365

Review 6.  Considerations for Heart Failure Care During the COVID-19 Pandemic.

Authors:  Ersilia M DeFilippis; Nosheen Reza; Elena Donald; Michael M Givertz; JoAnn Lindenfeld; Mariell Jessup
Journal:  JACC Heart Fail       Date:  2020-06-03       Impact factor: 12.035

Review 7.  Mechanical circulatory support-Challenges, strategies, and preparations.

Authors:  Wael I Awad; Mohamad Bashir
Journal:  J Card Surg       Date:  2021-01-13       Impact factor: 1.778

8.  Relationship between spleen size and exercise tolerance in advanced heart failure patients with a left ventricular assist device.

Authors:  Hiroaki Hiraiwa; Takahiro Okumura; Akinori Sawamura; Takashi Araki; Takashi Mizutani; Shingo Kazama; Yuki Kimura; Naoki Shibata; Hideo Oishi; Tasuku Kuwayama; Toru Kondo; Kenji Furusawa; Ryota Morimoto; Takuji Adachi; Sumio Yamada; Masato Mutsuga; Akihiko Usui; Toyoaki Murohara
Journal:  BMC Res Notes       Date:  2022-02-10

9.  Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device.

Authors:  Anna Scaglione; Claudia Panzarino; Maddalena Modica; Monica Tavanelli; Antonio Pezzano; Paola Grati; Vittorio Racca; Anastasia Toccafondi; Bruno Bordoni; Alessandro Verde; Iside Cartella; Paolo Castiglioni
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

Review 10.  Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence.

Authors:  Carlotta Sciaccaluga; Nicolò Ghionzoli; Giulia Elena Mandoli; Flavio D'Ascenzi; Marta Focardi; Serafina Valente; Matteo Cameli
Journal:  Biomolecules       Date:  2022-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.